Tvardi Therapeutics logo

Tvardi Therapeutics Share Price (NASDAQ: TVRD)

$29.98

-0.29

(-0.96%)

Last updated on

Check the interactive Tvardi Therapeutics Stock chart to analyse performance

Tvardi Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$29.48
    Today's High:$30.69

    Day's Volatility :3.94%

  • 52 Weeks Low:$15.13
    52 Weeks High:$34.31

    52 Weeks Volatility :55.9%

Tvardi Therapeutics Stock Returns

PeriodTvardi Therapeutics IncIndex (Russel 2000)
3 Months
-0.92%
0.0%
6 Months
61.55%
0.0%
1 Year
61.55%
0.0%
3 Years
61.55%
-4.7%

Tvardi Therapeutics Inc Key Stats

Check Tvardi Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$30.27
Open
$30.69
Today's High
$30.69
Today's Low
$29.48
Market Capitalization
$242.3M
Today's Volume
$14.3K
52 Week High
$34.31
52 Week Low
$15.1301
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-2.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Tvardi Therapeutics Stock including INR - Dollar returns

The Tvardi Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tvardi Therapeutics investment value today

Current value as on today

₹1,69,558

Returns

₹69,558

(+69.56%)

Returns from Tvardi Therapeutics Stock

₹64,274 (+64.27%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Tvardi Therapeutics Stock

44%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Tvardi Therapeutics Stock from India on INDmoney has increased by 44% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Tvardi Therapeutics Stock

Rating
Trend

Tvardi Therapeutics Share Price Target

What analysts predicted

Upside of 87.46%

Target:

$56.20

Current:

$29.98

Tvardi Therapeutics share price target is $56.20, a slight Upside of 87.46% compared to current price of $29.98 as per analysts' prediction.

Tvardi Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, TVRD stock has moved up by 5.1%

Tvardi Therapeutics Technicals Summary

Sell

Neutral

Buy

Tvardi Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Tvardi Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tvardi Therapeutics Inc logo
12.52%
61.55%
61.55%
61.55%
61.55%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Tvardi Therapeutics Inc

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 2 clinical development for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in pre-clinical stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Organization
Tvardi Therapeutics
Employees
11
CEO
Dr. Imran Alibhai Ph.D.
Industry
Miscellaneous

Key Management of Tvardi Therapeutics Inc

NameTitle
Dr. Imran Alibhai Ph.D.
CEO & Director
Mr. Wallace Hall
Founder, President & Director
Mr. Dan Conn J.D., M.B.A.
Chief Financial Officer
Dr. John Kauh M.D.
Chief Medical Officer
Mr. David J. Tweardy M.D.
Co-Founder & Scientific Advisory Board Member
Dr. Ronald A. DePinho M.D.
Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael T. Lewis Ph.D.
Co-Founder & Scientific Advisory Board Member
Dr. Jeffrey Larson DABT, Ph.D.
Senior Vice President of R&D
Mr. Stephen O'Brien CPA
VP of Finance & Corporate Controller
Dr. Yixin Chen Ph.D.
Vice President of CMC

Important FAQs about investing in TVRD Stock from India :

What is Tvardi Therapeutics share price today?

Tvardi Therapeutics share price today is $29.98 as on at the close of the market. Tvardi Therapeutics share today touched a day high of $30.69 and a low of $29.48.

What is the 52 week high and 52 week low for Tvardi Therapeutics share?

Tvardi Therapeutics share touched a 52 week high of $34.31 and a 52 week low of $15.13. Tvardi Therapeutics stock price today i.e. is closed at $29.98, lower by 12.62% versus the 52 week high.

How to invest in Tvardi Therapeutics Stock (TVRD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tvardi Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tvardi Therapeutics Shares that will get you 0.0500 shares as per Tvardi Therapeutics share price of $29.98 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tvardi Therapeutics Stock (TVRD) from India?

Indian investors can start investing in Tvardi Therapeutics (TVRD) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Tvardi Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Tvardi Therapeutics share’s latest price of $29.98 as on August 30, 2025 at 1:29 am IST, you will get 0.3336 shares of Tvardi Therapeutics. Learn more about fractional shares .

What are the returns that Tvardi Therapeutics has given to Indian investors in the last 5 years?

Tvardi Therapeutics stock has given 61.55% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?